218 related articles for article (PubMed ID: 35841044)
1. 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson's disease are associated with LRRC37A/2 expression in astrocytes.
Bowles KR; Pugh DA; Liu Y; Patel T; Renton AE; Bandres-Ciga S; Gan-Or Z; Heutink P; Siitonen A; Bertelsen S; Cherry JD; Karch CM; Frucht SJ; Kopell BH; Peter I; Park YJ; ; Charney A; Raj T; Crary JF; Goate AM
Mol Neurodegener; 2022 Jul; 17(1):48. PubMed ID: 35841044
[TBL] [Abstract][Full Text] [Related]
2. Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue.
Tauber CV; Schwarz SC; Rösler TW; Arzberger T; Gentleman S; Windl O; Krumbiegel M; Reis A; Ruf VC; Herms J; Höglinger GU
Acta Neuropathol Commun; 2023 Mar; 11(1):40. PubMed ID: 36906636
[TBL] [Abstract][Full Text] [Related]
3. Common inversion polymorphism at 17q21.31 affects expression of multiple genes in tissue-specific manner.
de Jong S; Chepelev I; Janson E; Strengman E; van den Berg LH; Veldink JH; Ophoff RA
BMC Genomics; 2012 Sep; 13():458. PubMed ID: 22950410
[TBL] [Abstract][Full Text] [Related]
4. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.
Tobin JE; Latourelle JC; Lew MF; Klein C; Suchowersky O; Shill HA; Golbe LI; Mark MH; Growdon JH; Wooten GF; Racette BA; Perlmutter JS; Watts R; Guttman M; Baker KB; Goldwurm S; Pezzoli G; Singer C; Saint-Hilaire MH; Hendricks AE; Williamson S; Nagle MW; Wilk JB; Massood T; Laramie JM; DeStefano AL; Litvan I; Nicholson G; Corbett A; Isaacson S; Burn DJ; Chinnery PF; Pramstaller PP; Sherman S; Al-hinti J; Drasby E; Nance M; Moller AT; Ostergaard K; Roxburgh R; Snow B; Slevin JT; Cambi F; Gusella JF; Myers RH
Neurology; 2008 Jul; 71(1):28-34. PubMed ID: 18509094
[TBL] [Abstract][Full Text] [Related]
5. Screening non-MAPT genes of the Chr17q21 H1 haplotype in Parkinson's disease.
Soto-Beasley AI; Walton RL; Valentino RR; Hook PW; Labbé C; Heckman MG; Johnson PW; Goff LA; Uitti RJ; McLean PJ; Springer W; McCallion AS; Wszolek ZK; Ross OA
Parkinsonism Relat Disord; 2020 Sep; 78():138-144. PubMed ID: 32829096
[TBL] [Abstract][Full Text] [Related]
6. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease.
Zabetian CP; Hutter CM; Factor SA; Nutt JG; Higgins DS; Griffith A; Roberts JW; Leis BC; Kay DM; Yearout D; Montimurro JS; Edwards KL; Samii A; Payami H
Ann Neurol; 2007 Aug; 62(2):137-44. PubMed ID: 17514749
[TBL] [Abstract][Full Text] [Related]
7. Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy.
Ezquerra M; Pastor P; Gaig C; Vidal-Taboada JM; Cruchaga C; Muñoz E; Martí MJ; Valldeoriola F; Aguilar M; Calopa M; Hernandez-Vara J; Tolosa E
Neurobiol Aging; 2011 Mar; 32(3):547.e11-6. PubMed ID: 19879020
[TBL] [Abstract][Full Text] [Related]
8. Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease.
Refenes N; Bolbrinker J; Tagaris G; Orlacchio A; Drakoulis N; Kreutz R
BMC Neurol; 2009 Jun; 9():26. PubMed ID: 19558713
[TBL] [Abstract][Full Text] [Related]
9. SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians.
Huang Y; Wang G; Rowe D; Wang Y; Kwok JB; Xiao Q; Mastaglia F; Liu J; Chen SD; Halliday G
Biomed Res Int; 2015; 2015():135674. PubMed ID: 25960998
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology.
Wider C; Ross OA; Nishioka K; Heckman MG; Vilariño-Güell C; Jasinska-Myga B; Erketin-Taner N; Rademakers R; Graff-Radford NR; Mash DC; Papapetropoulos S; Duara R; Uchikado H; Wszolek ZK; Farrer MJ; Dickson DW
J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):424-9. PubMed ID: 22291217
[TBL] [Abstract][Full Text] [Related]
11. Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease.
Vandrovcova J; Pittman AM; Malzer E; Abou-Sleiman PM; Lees AJ; Wood NW; de Silva R
Neurobiol Aging; 2009 Sep; 30(9):1477-82. PubMed ID: 18162161
[TBL] [Abstract][Full Text] [Related]
12. Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21.
; ; Spencer CC; Plagnol V; Strange A; Gardner M; Paisan-Ruiz C; Band G; Barker RA; Bellenguez C; Bhatia K; Blackburn H; Blackwell JM; Bramon E; Brown MA; Brown MA; Burn D; Casas JP; Chinnery PF; Clarke CE; Corvin A; Craddock N; Deloukas P; Edkins S; Evans J; Freeman C; Gray E; Hardy J; Hudson G; Hunt S; Jankowski J; Langford C; Lees AJ; Markus HS; Mathew CG; McCarthy MI; Morrison KE; Palmer CN; Pearson JP; Peltonen L; Pirinen M; Plomin R; Potter S; Rautanen A; Sawcer SJ; Su Z; Trembath RC; Viswanathan AC; Williams NW; Morris HR; Donnelly P; Wood NW
Hum Mol Genet; 2011 Jan; 20(2):345-53. PubMed ID: 21044948
[TBL] [Abstract][Full Text] [Related]
13. Copy number variation analysis of the 17q21.31 region and its role in neurodegenerative diseases.
Cervera-Carles L; Pagonabarraga J; Pascual-Sedano B; Pastor P; Campolongo A; Fortea J; Blesa R; Alcolea D; Morenas-Rodríguez E; Sala I; Lleó A; Kulisevsky J; Clarimón J
Am J Med Genet B Neuropsychiatr Genet; 2016 Mar; 171B(2):175-80. PubMed ID: 26453547
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the complex role of MAPT-containing H1 and H2 haplotypes in neurodegenerative diseases.
Pedicone C; Weitzman SA; Renton AE; Goate AM
Mol Neurodegener; 2024 May; 19(1):43. PubMed ID: 38812061
[TBL] [Abstract][Full Text] [Related]
15. Transcript Variants of Genes Involved in Neurodegeneration Are Differentially Regulated by the APOE and MAPT Haplotypes.
Koks S; Pfaff AL; Bubb VJ; Quinn JP
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33804213
[TBL] [Abstract][Full Text] [Related]
16. Association of the MAPT locus with Parkinson's disease.
Wider C; Vilariño-Güell C; Jasinska-Myga B; Heckman MG; Soto-Ortolaza AI; Cobb SA; Aasly JO; Gibson JM; Lynch T; Uitti RJ; Wszolek ZK; Farrer MJ; Ross OA
Eur J Neurol; 2010 Mar; 17(3):483-6. PubMed ID: 19912324
[TBL] [Abstract][Full Text] [Related]
17. MAPT allele and haplotype frequencies in Nigerian Africans: Population distribution and association with Parkinson's disease risk and age at onset.
Okunoye O; Ojo OO; Abiodun O; Abubakar S; Achoru C; Adeniji O; Agabi O; Agulanna U; Akinyemi R; Ali M; Ani-Osheku I; Arigbodi O; Bello A; Erameh C; Farombi T; Fawale M; Imarhiagbe F; Iwuozo E; Komolafe M; Nwani P; Nwazor E; Nyandaiti Y; Obiabo Y; Odeniyi O; Odiase F; Ojini F; Onwuegbuzie G; Osaigbovo G; Osemwegie N; Oshinaike O; Otubogun F; Oyakhire S; Ozomma S; Samuel S; Taiwo F; Wahab K; Zubair Y; Hernandez D; Bandres-Ciga S; Blauwendraat C; Singleton A; Houlden H; Hardy J; Rizig M; Okubadejo N
Parkinsonism Relat Disord; 2023 Aug; 113():105517. PubMed ID: 37467655
[TBL] [Abstract][Full Text] [Related]
18. Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals.
Winder-Rhodes SE; Hampshire A; Rowe JB; Peelle JE; Robbins TW; Owen AM; Barker RA
Neurobiol Aging; 2015 Mar; 36(3):1519-28. PubMed ID: 25577413
[TBL] [Abstract][Full Text] [Related]
19. Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder.
Li J; Ruskey JA; Arnulf I; Dauvilliers Y; Hu MTM; Högl B; Leblond CS; Zhou S; Ambalavanan A; Ross JP; Bourassa CV; Spiegelman D; Laurent SB; Stefani A; Charley Monaca C; Cochen De Cock V; Boivin M; Ferini-Strambi L; Plazzi G; Antelmi E; Young P; Heidbreder A; Labbe C; Ferman TJ; Dion PA; Fan D; Desautels A; Gagnon JF; Dupré N; Fon EA; Montplaisir JY; Boeve BF; Postuma RB; Rouleau GA; Ross OA; Gan-Or Z
Mov Disord; 2018 Jul; 33(6):1016-1020. PubMed ID: 29756641
[TBL] [Abstract][Full Text] [Related]
20. H1/H2 MAPT haplotype and Parkinson's disease in Mexican mestizo population.
Miranda-Morales EG; Sandoval-Carrillo A; Castellanos-Juárez FX; Méndez-Hernández EM; La Llave-León O; Quiñones-Canales G; Ruano-Calderón LA; Arias-Carrión O; Salas-Pacheco JM
Neurosci Lett; 2019 Jan; 690():210-213. PubMed ID: 30339920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
